Orion Portfolio Solutions LLC Sells 10,298 Shares of Haleon plc (NYSE:HLN)

Orion Portfolio Solutions LLC lessened its stake in shares of Haleon plc (NYSE:HLN) by 2.6% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 379,174 shares of the company’s stock after selling 10,298 shares during the period. Orion Portfolio Solutions LLC’s holdings in Haleon were worth $3,617,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Thrivent Financial for Lutherans increased its holdings in Haleon by 69.0% in the 3rd quarter. Thrivent Financial for Lutherans now owns 55,593 shares of the company’s stock worth $588,000 after purchasing an additional 22,701 shares in the last quarter. Charles Schwab Investment Management Inc. increased its stake in shares of Haleon by 41.5% in the third quarter. Charles Schwab Investment Management Inc. now owns 203,583 shares of the company’s stock valued at $2,154,000 after buying an additional 59,719 shares during the period. Aureus Asset Management LLC raised its holdings in Haleon by 18.3% in the 3rd quarter. Aureus Asset Management LLC now owns 14,881 shares of the company’s stock valued at $157,000 after buying an additional 2,298 shares during the last quarter. Benjamin Edwards Inc. bought a new position in Haleon in the 3rd quarter valued at approximately $805,000. Finally, Hilltop Holdings Inc. acquired a new stake in Haleon during the 3rd quarter worth approximately $133,000. 6.67% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities analysts have issued reports on the stock. Sanford C. Bernstein cut shares of Haleon from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 8th. HSBC restated a “hold” rating on shares of Haleon in a report on Wednesday, March 5th. Hsbc Global Res downgraded Haleon from a “strong-buy” rating to a “hold” rating in a report on Wednesday, March 5th. Morgan Stanley cut Haleon from an “overweight” rating to an “equal weight” rating in a research note on Friday, January 10th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating on shares of Haleon in a research note on Monday, March 3rd. Six research analysts have rated the stock with a hold rating, one has assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $10.95.

Haleon Stock Performance

Shares of HLN opened at $10.24 on Monday. The firm’s fifty day simple moving average is $9.94 and its two-hundred day simple moving average is $9.87. Haleon plc has a 12 month low of $7.99 and a 12 month high of $10.80. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44. The stock has a market capitalization of $46.33 billion, a P/E ratio of 30.10, a price-to-earnings-growth ratio of 2.82 and a beta of 0.25.

Haleon (NYSE:HLN) last released its earnings results on Thursday, February 27th. The company reported $0.05 EPS for the quarter. The business had revenue of $3.54 billion during the quarter, compared to analysts’ expectations of $3.38 billion. Haleon had a return on equity of 14.76% and a net margin of 10.85%. As a group, analysts predict that Haleon plc will post 0.43 EPS for the current year.

Haleon Increases Dividend

The business also recently disclosed a — dividend, which will be paid on Thursday, June 5th. Stockholders of record on Friday, April 25th will be paid a $0.1166 dividend. The ex-dividend date of this dividend is Friday, April 25th. This represents a dividend yield of 1.6%. This is a positive change from Haleon’s previous — dividend of $0.05. Haleon’s payout ratio is currently 58.97%.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.